par Erdem, Rahsan;De Coster, Ilse;Withanage, Kanchanamala;Mercer, Laina LD;Marchant, Arnaud
;Taton, Martin
;Cools, Nathalie;Lion, Eva;Cassels, Fred;Higgins, Deborah;Ivinson, Karen;Locke, Emily;Mahmood, Kutub;Wright, Peter F;Gast, Chris;White, Jessica A;Ackerman, Margaret M.E.;Konopka-Anstadt, Jennifer JL;Mainou, Bernardo BA;Van Damme, Pierre
Référence Vaccine, 41, 10, page (1657-1667)
Publication Publié, 2023-03


Référence Vaccine, 41, 10, page (1657-1667)
Publication Publié, 2023-03
Article révisé par les pairs
Résumé : | Inactivated trivalent poliovirus vaccine (IPV) induces humoral immunity, which protects against paralytic poliomyelitis but does not induce sufficient mucosal immunity to block intestinal infection. We assessed the intestinal immunity in healthy adults in Belgium conferred by a co-formulation of IPV with the mucosal adjuvant double mutant Labile Toxin (dmLT) derived from Escherichia coli. |